Skip to main content

Diagnostic Utility of NGS Panel Testing Including Non-coding and Mitochondrial DNA Variants in Patients With Monogenic Diabetes

Sociedade Portuguesa de Genetica Humana
26th Annual Meeting

SPGH  2022

Coimbra, Portugal, November 17 - 19, 2022

Poster presentation: Diagnostic utility of NGS panel testing including non-coding and mitochondrial DNA variants in patients with monogenic diabetes

Authors: Scocchia A, Sánchez-Alcudia R, Känsäkoski J, Gall K, Hathaway J, Taylor A, Huusko J, Bernal M, von Nandelstadh P, Tommiska J, Saarinen I, Rantanen M, Schleit J, Gentile M, Salmenperä P, Paananen J, Myllykangas S, Koskenvuo J.

Specialties: Cardiology, Endocrinology, Genetics

Disclaimer:  One or more of the authors of this publication were employed at the time by Blueprint Genetics, a subsidiary of Quest Diagnostics.